Skip to content

Study on pathophysiology and clinical features of intractable and rare hepatobiliary and pancreatic disease and prognosis after treatment

Study on pathophysiology and clinical features of intractable and rare hepatobiliary and pancreatic disease and prognosis after treatment - Study on pathophysiology and clinical features of intractable and rare hepatobiliary and pancreatic disease and prognosis after treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042732
Enrollment
24
Registered
2020-12-11
Start date
2018-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreaticobiliary maljunction

Interventions

None listed

Sponsors

Osaka City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with pancreaticobiliary maljunctionwho underwent surgery at osaka city university

Exclusion criteria

Exclusion criteria: Patients with pancreaticobiliary maljunction who were referred to osaka city university after undergoing surgery at another hospital

Design outcomes

Primary

MeasureTime frame
Correlation between pancreatic duct and bile duct confluent angle, common bile duct morphology, bile duct diameter at the junction site and pathological findings of gallbladder epithelium

Countries

Japan

Contacts

Public ContactMasaki Horiike

Osaka City University pediatric surgery

masakihoriike1031@gmail.com0666453841

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026